Neural responses to social evaluative threat in the absence of negative investigator feedback and provoked performance failures.
Adult
Adverse Childhood Experiences
Amygdala
/ diagnostic imaging
Blood Pressure
/ physiology
Brain Mapping
Feedback, Psychological
/ physiology
Female
Gyrus Cinguli
/ diagnostic imaging
Heart Rate
/ physiology
Humans
Hydrocortisone
/ metabolism
Hypothalamo-Hypophyseal System
/ metabolism
Longitudinal Studies
Magnetic Resonance Imaging
Male
Pupil
/ physiology
Saliva
Social Behavior
Stress, Psychological
/ diagnostic imaging
Sympathetic Nervous System
/ metabolism
Urban Population
Young Adult
functional neuroimaging
mental health
risk factors
social perception
stress
Journal
Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065
Informations de publication
Date de publication:
01 06 2020
01 06 2020
Historique:
received:
21
08
2019
revised:
19
12
2019
accepted:
07
01
2020
pubmed:
21
1
2020
medline:
9
11
2021
entrez:
21
1
2020
Statut:
ppublish
Résumé
Functional neuroimaging of social stress induction has considerably furthered our understanding of the neural risk architecture of stress-related mental disorders. However, broad application of existing neuroimaging stress paradigms is challenging, among others due to the relatively high intensity of the employed stressors, which limits applications in patients and longitudinal study designs. Here, we introduce a less intense neuroimaging stress paradigm in which subjects anticipate, prepare, and give speeches under simulated social evaluation without harsh investigator feedback or provoked performance failures (IMaging Paradigm for Evaluative Social Stress, IMPRESS). We show that IMPRESS significantly increases perceived arousal as well as adrenergic (heart rate, pupil diameter, and blood pressure) and hormonal (cortisol) responses. Amygdala and perigenual anterior cingulate cortex (pACC), two key regions of the emotion and stress regulatory circuitry, are significantly engaged by IMPRESS. We further report associations of amygdala and pACC responses with measures of adrenergic arousal (heart rate, pupil diameter) and social environmental risk factors (adverse childhood experiences, urban living). Our data indicate that IMPRESS induces benchmark psychological and endocrinological responses to social evaluative stress, taps into core neural circuits related to stress processing and mental health risk, and is promising for application in mental illness and in longitudinal study designs.
Identifiants
pubmed: 31958212
doi: 10.1002/hbm.24932
pmc: PMC7268032
doi:
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2092-2103Informations de copyright
© 2020 The Authors. Human Brain Mapping published by Wiley Periodicals, Inc.
Références
Neuroimage. 2009 Sep;47(3):836-51
pubmed: 19465135
Nat Rev Neurosci. 2009 Jun;10(6):397-409
pubmed: 19469025
Neuropsychopharmacology. 2015 Aug;40(9):2278-85
pubmed: 25781268
Neuroimage. 2014 Dec;103:383-390
pubmed: 25284303
Mol Psychiatry. 2020 Feb;25(2):379-396
pubmed: 31628419
Psychoneuroendocrinology. 2017 Mar;77:25-36
pubmed: 28012291
Nat Neurosci. 2015 Oct;18(10):1353-63
pubmed: 26404710
Psychoneuroendocrinology. 2012 Dec;37(12):1998-2008
pubmed: 22608857
Neuropsychobiology. 1993;28(1-2):76-81
pubmed: 8255414
Curr Opin Psychiatry. 2018 May;31(3):231-236
pubmed: 29474264
Psychophysiology. 2005 Nov;42(6):627-35
pubmed: 16364058
J Psychiatry Neurosci. 2005 Sep;30(5):319-25
pubmed: 16151536
Int J Psychophysiol. 2011 Feb;79(2):118-26
pubmed: 20875462
Biol Psychol. 2012 Jan;89(1):99-106
pubmed: 22001447
Curr Dir Psychol Sci. 2015 Aug 1;24(4):313-321
pubmed: 26279608
Psychosom Med. 1999 Mar-Apr;61(2):154-62
pubmed: 10204967
J Neural Transm (Vienna). 2019 Sep;126(9):1187-1202
pubmed: 30631946
Psychoneuroendocrinology. 2015 Jan;51:414-25
pubmed: 25462913
Hum Brain Mapp. 2020 Jun 1;41(8):2092-2103
pubmed: 31958212
Can J Psychiatry. 2009 Jan;54(1):6-15
pubmed: 19175975
Stress. 2014 Jul;17(4):352-61
pubmed: 24800784
Psychoneuroendocrinology. 2003 Oct;28(7):916-31
pubmed: 12892658
J Neurosci. 2008 Jan 23;28(4):990-9
pubmed: 18216206
Am J Psychiatry. 2001 Aug;158(8):1220-6
pubmed: 11481154
Hypertension. 2007 Jan;49(1):134-40
pubmed: 17101844
Psychol Med. 2016 Apr;46(5):1037-54
pubmed: 26670947
Nat Neurosci. 2012 Apr 15;15(5):663-8
pubmed: 22504349
J Am Heart Assoc. 2017 Aug 23;6(9):
pubmed: 28835356
Nat Neurosci. 2005 Jun;8(6):828-34
pubmed: 15880108
Psychoneuroendocrinology. 2008 Jul;33(6):890-5
pubmed: 18403130
Psychother Psychosom Med Psychol. 2010 Aug;60(8):e13
pubmed: 20361390
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
Soc Cogn Affect Neurosci. 2007 Sep;2(3):161-73
pubmed: 18418472
N Engl J Med. 1999 Feb 25;340(8):603-8
pubmed: 10029644
Neuroimage. 2019 Apr 1;189:870-877
pubmed: 30703518
Biol Psychiatry. 2012 Feb 15;71(4):286-93
pubmed: 22112927
Dev Psychopathol. 2018 Oct;30(4):1475-1485
pubmed: 29224580
JAMA Psychiatry. 2014 Jun;71(6):672-80
pubmed: 24740491
Psychiatry Res. 2013 Feb 28;211(2):93-103
pubmed: 23154098
Psychol Med. 2018 May;48(7):1092-1101
pubmed: 29429419
Biol Psychiatry. 2015 Dec 15;78(12):830-9
pubmed: 25823790
Nature. 2011 Jun 22;474(7352):498-501
pubmed: 21697947
Neuroimage. 2018 May 1;171:311-322
pubmed: 29329979
Nat Rev Neurosci. 2001 Jun;2(6):417-24
pubmed: 11389475
J Behav Ther Exp Psychiatry. 1994 Mar;25(1):49-59
pubmed: 7962581
J Neurosci. 1993 Sep;13(9):3839-47
pubmed: 8396170
Nat Rev Neurosci. 2016 Sep 19;17(10):652-66
pubmed: 27640984
Neuroimage. 2009 Sep;47(3):821-35
pubmed: 19465137
Psychol Bull. 2004 May;130(3):355-91
pubmed: 15122924
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1201-13
pubmed: 16271821
Hum Brain Mapp. 2013 Nov;34(11):2899-909
pubmed: 22696400
Nat Neurosci. 2015 Oct;18(10):1421-31
pubmed: 26404717
Neuroscience. 2019 Sep 15;416:190-197
pubmed: 31400483
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
Biol Psychiatry. 2002 Dec 1;52(11):1113-9
pubmed: 12460694
Ann N Y Acad Sci. 2004 Dec;1032:1-7
pubmed: 15677391
Lancet Psychiatry. 2019 Oct;6(10):830-839
pubmed: 31519507